Proton Therapy For
Gastrointestinal Cancers
How Proton Therapy Improves GI Cancer Treatment
Proton Therapy has the dexterity to move deep within the body to treat hard-to-reach cancers in the GI tract, without posing a substantial threat to the digestive system and neighboring organs. This limits potential side effects that can negatively impact the patient’s health and quality of life during treatment. Proton Therapy also increases treatment options for the patient because unlike traditional radiation therapy, it can be safely combined with surgery.
Common Gastrointestinal Cancers Treated with Proton Therapy:
- Colon
- Pancreatic
- Liver
- Esophagus
- Stomach
- Bile duct
- Rectum
“Proton therapy has proven to be a highly effective treatment for patients living with esophageal cancer.
Recent research has shown that proton therapy can be an effective treatment option for patients living with esophageal cancer, associated with fewer post-operative complications and shorter hospital stays. A 2013 study of nearly 450 patients with esophageal cancer found that those who received proton therapy had fewer gastrointestinal and pulmonary toxicities than patients who received photon therapy.” said Daniel E. Smith, President of the Alliance for Proton Therapy Access.
To speak with our staff regarding the treatment of Gastrointestinal cancers,
Click or Call +1-678-871-1009
Request Information
Click or Call +1-678-871-1009


Meet Dr. Rich
Dr. Tyvin A. Rich specializes in the treatment of gastrointestinal and lung cancers. With more than 30 years of experience, he is recognized in the United States as one of the top doctors in his field. Dr. Rich has received numerous awards for leadership and clinical excellence and is a prolific author, having published more than 200 papers and book chapters in his area of specialty.
Pancreas tumors are very frustrating and difficult because the pancreas is right next to the duodenum—the bowel—and that limits the dose of conventional therapy we can use. But proton therapy gives us a technique that we believe can help patients with pancreatic tumors.